Why is Medicamen Organ. falling/rising?

As of 29-Sep, Medicamen Organics Ltd is experiencing a decline in its stock price, currently at 31.65, which represents a decrease of 1.65 or 4.95%. The stock has underperformed its sector by 5.09% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 46.43% compared to the 5-day average. Over the past week, the stock has decreased by 9.70%, and its year-to-date performance shows a substantial decline of 41.28%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the stock's short-term performance has been notably worse than the benchmark, with the Sensex only declining by 2.25% over the same week. While the Sensex has shown a slight increase of 0.85% over the past month, Medicamen Organics Ltd has seen a more significant drop of 13.17% in that timeframe. This stark contrast highlights the stock's underperformance relative to the overall market, indicating a challenging environment for the company amidst broader market trends.